2020
Trends of HIV, hepatitis C virus and syphilis seroprevalence among injection and non-injection drug users in southwestern China, 2010–2017
Jiang H, Zhang X, Zhang C, Lu R, Zhou C, Ouyang L, Xing H, Vermund SH, Shao Y, Ruan Y, Wu G, Qian HZ. Trends of HIV, hepatitis C virus and syphilis seroprevalence among injection and non-injection drug users in southwestern China, 2010–2017. AIDS Care 2020, 36: 612-617. PMID: 33345591, PMCID: PMC10767711, DOI: 10.1080/09540121.2020.1856320.Peer-Reviewed Original ResearchNon-injection drug usersHepatitis C virusDrug use behaviorsDrug usersHCV prevalenceC virusRisky drug use behaviorsTrends of HIVCross-sectional surveySyphilis seroprevalenceHIV prevalenceHIV transmissionPrevalence trendsPWIDDrug useHIVDisease preventionSexual contactUse behaviorsChi-squarePrevalenceSyphilisDrugsVirusPrimary risk
2006
Correlates of Syphilis Seroreactivity Among Pregnant Women: The HIVNET 024 Trial in Malawi, Tanzania, and Zambia
Potter D, Goldenberg RL, Read JS, Wang J, Hoffman IF, Saathoff E, Kafulafula G, Aboud S, Martinson FE, Dahab M, Vermund SH. Correlates of Syphilis Seroreactivity Among Pregnant Women: The HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sexually Transmitted Diseases 2006, 33: 604-609. PMID: 16601659, PMCID: PMC2743105, DOI: 10.1097/01.olq.0000216029.00424.ae.Peer-Reviewed Original ResearchConceptsSub-Saharan African settingHistory of stillbirthCross-sectional studyMultisite clinical trialSyphilis preventionSyphilis seroprevalenceSyphilis seroreactivityAntenatal attendeesPreterm deliveryYoung HIVAntenatal HIVHIV infectionPregnant womenSyphilis screeningRisk factorsClinical trialsUlcer treatmentHigh riskHIVAge 20African settingWomenSignificant correlatesTrialsCorrelates